Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;236(6):4138-4151.
doi: 10.1002/jcp.30197. Epub 2020 Dec 4.

Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets

Benhui Liang  1   2 , Ximin Hu  1   3 , Yinghe Ding  1   3 , Mujun Liu  1
Affiliations
Review

Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets

Benhui Liang et al. J Cell Physiol. 2021 Jun.

Abstract

Programmed cell death-1 (PD-1) is a negative coreceptor mainly expressed on the surface of activated T cells. The binding of PD-1 to its ligand PD-L1 significantly induces non-reactivity of T cells to maintain the balance of autoimmunity and immune tolerance. It is reported that tumor cells highly express PD-L1 to restrict cellular immune response, which is one of the most important mechanisms for tumor to mediate immune escape. Cancer immunotherapy targeting PD-1/PD-L1 has achieved remarkable success so far. Tumor-derived exosomes (TEXs) are lipid bilayer vesicles released by tumor cells in an endosome-dependent manner, mediating communication between tumor cells and adjacent cells in the tumor microenvironment. Through signals transmitted by TEXs, tumor can alter the biological characteristics of these cells to promote tumor growth and metastasis. Recent studies have demonstrated that TEXs not only carry tumor-derived PD-L1, but are also closely related to PD-1/PD-L1 expression on target cells. The primary focus of this review will be on how TEXs regulate the PD-1/PD-L1 axis to promote tumor progression, and the promising clinical applications targeting TEXs and exosomal PD-L1.

Keywords: PD-1/PD-L1 axis; cancer immunotherapy; exosomal PD-L1; tumor immune escape; tumor-derived exosomes.

PubMed Disclaimer

References

REFERENCES

    1. Biswas, S., Mandal, G., Roy Chowdhury, S., Purohit, S., Payne, K. K., Anadon, C., Gupta, A., Swanson, P., Yu, X., Conejo-Garcia, J. R., & Bhattacharyya, A. (2019). Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer. Journal of Immunology, 203(12), 3447-3460. https://doi.org/10.4049/jimmunol.1900692
    1. Boussadia, Z., Lamberti, J., Mattei, F., Pizzi, E., Puglisi, R., Zanetti, C., Pasquini, L., Fratini, F., Fantozzi, L., Felicetti, F., Fecchi, K., Raggi, C., Sanchez, M., D'Atri, S., Carè, A., Sargiacomo, M., & Parolini, I. (2018). Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules. Journal of Experimental & Clinical Cancer Research, 37(1), 245. https://doi.org/10.1186/s13046-018-0915-z
    1. Chen, G., Huang, A. C., Zhang, W., Zhang, G., Wu, M., Xu, W., Yu, Z., Yang, J., Wang, B., Sun, H., Xia, H., Man, Q., Zhong, W., Antelo, L. F., Wu, B., Xiong, X., Liu, X., Guan, L., Li, T., … Guo, W. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature, 560(7718), 382-386. https://doi.org/10.1038/s41586-018-0392-8
    1. Chen, Z., You, L., Wang, L., Huang, X., Liu, H., Wei, J., Zhu, L., & Qian, W. (2018). Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo. Journal of Experimental & Clinical Cancer Research, 37(1), 190. https://doi.org/10.1186/s13046-018-0863-7
    1. Cheng, L., Liu, J., Liu, Q., Liu, Y., Fan, L., Wang, F., Yu, H., Li, Y., Bu, L., Li, X., Wei, W., Wang, H., & Sun, G. (2017). Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages. International Journal of Biological Sciences, 13(6), 723-734. https://doi.org/10.7150/ijbs.19642

Publication types

MeSH terms

LinkOut - more resources